Deciphering a Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Clear Cell Renal Carcinoma

Figure 3

Prognostic analysis of necroptosis-related miRNA (NRM) signature in training, testing, and whole TCGA cohorts. (a) Risk line and risk point plots show the survival rate and risk score of each patient in the training cohort. (b) Kaplan–Meier plot of patients in the high- and low-risk groups in the training cohort. (c) ROC curve shows the prognostic performance of the NRM signature in the training cohort. (d) Risk line and risk point plots show the survival rate and risk score of each patient in the testing cohort. (e) Kaplan–Meier plot of patients in the high- and low-risk groups in the testing cohort. (f) ROC curve shows the prognostic performance of the NRM signature in the testing cohort. (g) Risk line and risk point plots show the survival rate and risk score of each patient in the entire TCGA cohort. (h) Kaplan–Meier plot of patients in the high- and low-risk groups in the entire TCGA cohort. (i) The ROC curve shows the prognostic performance of the NRM signature in the entire TCGA cohort.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)